The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccine Testing Service Market Research Report 2024
Synopsis
The global Vaccine Testing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Vaccine Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vaccine Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Vaccine Testing Service in Inactivated Vaccine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Vaccine Testing Service include RSSL, Labcorp Drug Development, Nexelis, Charles River Laboratories, PPD, WuXi Biologics, NIBSC and Valneva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vaccine Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Testing Service.
Report Scope
The Vaccine Testing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
RSSL
Labcorp Drug Development
Nexelis
Charles River Laboratories
PPD
WuXi Biologics
NIBSC
Valneva
Segment by Type
Physical and Chemical Testing
Microbial Detection
Immunological Testing
Others
Segment by Application
Inactivated Vaccine
Subunit Vaccine
Toxoid Vaccine
mRNA Vaccine
Viral Vector Vaccine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Vaccine Testing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Vaccine Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vaccine Testing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Vaccine Testing Service in Inactivated Vaccine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Vaccine Testing Service include RSSL, Labcorp Drug Development, Nexelis, Charles River Laboratories, PPD, WuXi Biologics, NIBSC and Valneva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vaccine Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Testing Service.
Report Scope
The Vaccine Testing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
RSSL
Labcorp Drug Development
Nexelis
Charles River Laboratories
PPD
WuXi Biologics
NIBSC
Valneva
Segment by Type
Physical and Chemical Testing
Microbial Detection
Immunological Testing
Others
Segment by Application
Inactivated Vaccine
Subunit Vaccine
Toxoid Vaccine
mRNA Vaccine
Viral Vector Vaccine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Testing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Physical and Chemical Testing
1.2.3 Microbial Detection
1.2.4 Immunological Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccine Testing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Inactivated Vaccine
1.3.3 Subunit Vaccine
1.3.4 Toxoid Vaccine
1.3.5 mRNA Vaccine
1.3.6 Viral Vector Vaccine
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Testing Service Market Perspective (2019-2030)
2.2 Vaccine Testing Service Growth Trends by Region
2.2.1 Global Vaccine Testing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaccine Testing Service Historic Market Size by Region (2019-2024)
2.2.3 Vaccine Testing Service Forecasted Market Size by Region (2025-2030)
2.3 Vaccine Testing Service Market Dynamics
2.3.1 Vaccine Testing Service Industry Trends
2.3.2 Vaccine Testing Service Market Drivers
2.3.3 Vaccine Testing Service Market Challenges
2.3.4 Vaccine Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Testing Service Players by Revenue
3.1.1 Global Top Vaccine Testing Service Players by Revenue (2019-2024)
3.1.2 Global Vaccine Testing Service Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Testing Service Revenue
3.4 Global Vaccine Testing Service Market Concentration Ratio
3.4.1 Global Vaccine Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Testing Service Revenue in 2023
3.5 Vaccine Testing Service Key Players Head office and Area Served
3.6 Key Players Vaccine Testing Service Product Solution and Service
3.7 Date of Enter into Vaccine Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Testing Service Breakdown Data by Type
4.1 Global Vaccine Testing Service Historic Market Size by Type (2019-2024)
4.2 Global Vaccine Testing Service Forecasted Market Size by Type (2025-2030)
5 Vaccine Testing Service Breakdown Data by Application
5.1 Global Vaccine Testing Service Historic Market Size by Application (2019-2024)
5.2 Global Vaccine Testing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaccine Testing Service Market Size (2019-2030)
6.2 North America Vaccine Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vaccine Testing Service Market Size by Country (2019-2024)
6.4 North America Vaccine Testing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Testing Service Market Size (2019-2030)
7.2 Europe Vaccine Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vaccine Testing Service Market Size by Country (2019-2024)
7.4 Europe Vaccine Testing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Testing Service Market Size (2019-2030)
8.2 Asia-Pacific Vaccine Testing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vaccine Testing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Vaccine Testing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Testing Service Market Size (2019-2030)
9.2 Latin America Vaccine Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vaccine Testing Service Market Size by Country (2019-2024)
9.4 Latin America Vaccine Testing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Testing Service Market Size (2019-2030)
10.2 Middle East & Africa Vaccine Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vaccine Testing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Vaccine Testing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 RSSL
11.1.1 RSSL Company Detail
11.1.2 RSSL Business Overview
11.1.3 RSSL Vaccine Testing Service Introduction
11.1.4 RSSL Revenue in Vaccine Testing Service Business (2019-2024)
11.1.5 RSSL Recent Development
11.2 Labcorp Drug Development
11.2.1 Labcorp Drug Development Company Detail
11.2.2 Labcorp Drug Development Business Overview
11.2.3 Labcorp Drug Development Vaccine Testing Service Introduction
11.2.4 Labcorp Drug Development Revenue in Vaccine Testing Service Business (2019-2024)
11.2.5 Labcorp Drug Development Recent Development
11.3 Nexelis
11.3.1 Nexelis Company Detail
11.3.2 Nexelis Business Overview
11.3.3 Nexelis Vaccine Testing Service Introduction
11.3.4 Nexelis Revenue in Vaccine Testing Service Business (2019-2024)
11.3.5 Nexelis Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Detail
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Vaccine Testing Service Introduction
11.4.4 Charles River Laboratories Revenue in Vaccine Testing Service Business (2019-2024)
11.4.5 Charles River Laboratories Recent Development
11.5 PPD
11.5.1 PPD Company Detail
11.5.2 PPD Business Overview
11.5.3 PPD Vaccine Testing Service Introduction
11.5.4 PPD Revenue in Vaccine Testing Service Business (2019-2024)
11.5.5 PPD Recent Development
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Detail
11.6.2 WuXi Biologics Business Overview
11.6.3 WuXi Biologics Vaccine Testing Service Introduction
11.6.4 WuXi Biologics Revenue in Vaccine Testing Service Business (2019-2024)
11.6.5 WuXi Biologics Recent Development
11.7 NIBSC
11.7.1 NIBSC Company Detail
11.7.2 NIBSC Business Overview
11.7.3 NIBSC Vaccine Testing Service Introduction
11.7.4 NIBSC Revenue in Vaccine Testing Service Business (2019-2024)
11.7.5 NIBSC Recent Development
11.8 Valneva
11.8.1 Valneva Company Detail
11.8.2 Valneva Business Overview
11.8.3 Valneva Vaccine Testing Service Introduction
11.8.4 Valneva Revenue in Vaccine Testing Service Business (2019-2024)
11.8.5 Valneva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
